Search results
FDA advisers consider MDMA therapy to treat PTSD
CNN via AOL· 7 hours agoA federal advisory committee meets today to weigh the risks and benefits of using MDMA, commonly known as ecstasy, as a treatment for post-traumatic...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
KAAL Austin· 3 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
With MDMA on the brink of FDA approval, psychedelic medicine faces a critical moment
Market Watch· 2 hours agoOne key issue: Due to the intense effects of MDMA, trial participants and researchers may have a...
William Blair Commentary: Waistlines and GLP1-s--Expanding in Unison
GuruFocus.com via Yahoo Finance· 2 hours agoFood & Drug Administration (FDA) approved the first commercial GLP-1 medication for the treatment of...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks via Yahoo Finance· 2 hours agoTeva and Sanofi will equally share the development costs globally. Teva faced several lawsuits from...
FDA responds to senator’s letter that calls out ‘FDA’s failure to act’ on NOW’s test results
Nutraingredients.com· 4 days agoLast April, South Carolina Congressman Jeff Duncan wrote to FDA Commissioner Dr. Robert Califf,...
FDA Roundup: May 28, 2024
The Pilot News· 7 days agoOn Friday, the FDA announced it had opened a new period for applications for grants to support the development and potential approval or conditional approval of new animal ...